** Shares of Chinese biopharmaceutical products developer
Transcenta Holding Ltd 6628.HK fall to HK$12.08 in debut, down
24.5% from the offering price
** Stock last down 23.1% from the offering price of HK$16
each
** Anhui, China-based co sold 40.33 mln shares in global
offering, raising HK$645 mln ($5.02 bln) urn:newsml:reuters.com:*:nFWN2QF0Z2
** Co to use proceeds to fund R&D of its pipeline product
candidates and clinical and pre-clinical trials, and for
commercialisation of products
** Dongguan Rural Commercial Bank Co Ltd 9889.HK falls as
much as 17.8% from the offering price of HK$7.92/share in debut
** Shares last down 16.7% at HK$6.60
** Guangdong, China-based bank sold 1.15 bln shares in
global offering, raising HK$9.11 bln urn:newsml:reuters.com:*:nFWN2QH146
** It would use proceeds to strengthen capital base to
support business growth and optimise asset portfolios to
prioritise investments in loan placement
** The Hang Seng Composite Index tracking financials
.HSCIF climbs 0.7%, while the healthcare index .HSCIH drops
2.4%
** The Hang Seng China Enterprises Index .HSCE slips 1.2%
and the benchmark index .HSI eases 0.8%
($1 = 0.1284 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))